Built on strength and balance, Sixty Degree Capital invests in the evolving areas of biopharmaceuticals, healthcare platforms and technology. Engaging with companies throughout North America, we aim to remove the barriers between us and our potential in order to make present visions a reality.
12
Total Investments
11
Portfolio Companies
-
Exits
-
Industries
General Information
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About 60 Degree Capital
Recent Investments (12)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series E | •••••• | Mar 2024 | |
| Venture Round | •••••• | Nov 2022 | |
| Series D | •••••• | Jul 2022 | |
| Series E | •••••• | Mar 2022 | |
| Convertible Note | •••••• | Feb 2022 | |
|
|
Series A | •••••• | Jan 2022 |
|
|
Convertible Note | •••••• | Nov 2021 |
|
|
Series D | •••••• | Jul 2021 |
|
|
Series D | •••••• | Jul 2021 |
|
|
Series D | •••••• | Oct 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.